NCT06055504 is a NA clinical trial of Control Strategy in Non-ischemic Dilated Cardiomyopathy, sponsored by Consorcio Centro de Investigación Biomédica en Red (CIBER).

Who is sponsoring NCT06055504?

NCT06055504 is sponsored by Consorcio Centro de Investigación Biomédica en Red (CIBER).

What drugs are being tested in NCT06055504?

Interventions in NCT06055504: Control Strategy, Personalized precision ICD implantation Strategy based in genetic findings and CMR results.

What condition does NCT06055504 study?

NCT06055504 studies Non-ischemic Dilated Cardiomyopathy.

Is NCT06055504 still recruiting?

NCT06055504 is currently recruiting now. Last updated 28 February 2024.

Last reviewed 2024-02-28 · How we verify

NCT06055504

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of Personalized Allocation of Defibrillators in Non-ischemic Heart Failure (SPANISH-1)

Recruiting now NA Last updated 28 February 2024

What this trial tests

NA trial testing Control Strategy in Non-ischemic Dilated Cardiomyopathy in 900 participants. Currently enrolling.

Timeline

6 September 2023

Primary endpoint
1 October 2025

1 October 2027

Quick facts

Lead sponsor	Consorcio Centro de Investigación Biomédica en Red (CIBER)
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	900
Start date	6 September 2023
Primary completion	1 October 2025
Estimated completion	1 October 2027
Sites	31 locations across Spain

Drugs / interventions tested

Control Strategy
Personalized precision ICD implantation Strategy based in genetic findings and CMR results

Conditions studied

Non-ischemic Dilated Cardiomyopathy — all drugs for Non-ischemic Dilated Cardiomyopathy →

Sponsor

Consorcio Centro de Investigación Biomédica en Red (CIBER) — full company profile →

Who can join

18 and older, any sex, with Non-ischemic Dilated Cardiomyopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, randomised, multicentre, open-label study to assess the non-inferiority of a personalised precision strategy for Sudden Cardiac Death (SCD) prevention in patients with non-ischemic dilated cardiomyopathy with Left Ventricular Ejection Fraction (LVEF) ≤35%

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prognostic value of late gadolinium enhancement cardiac MRI for ICD therapy in non-ischaemic cardiomyopathy : A 5-year cohort study.
Hopman LHGA, Becker MAJ, de Haas SHM, van der Lingen ACJ, et al · · 2025 · cited 1× · PMID 40131643 · DOI 10.1007/s12471-025-01946-3

Verify or expand the search:

Other recruiting trials for Non-ischemic Dilated Cardiomyopathy

Currently open trials in the same condition.

NCT05760924 — Left Bundle Branch Pacing on Outcomes and Ventricular Remodeling in Biventricular CRT Nonresponders · NA · recruiting
NCT05769036 — Conventional Biventricular Versus Left Bundle Branch Pacing on Outcomes in Heart Failure Patients · NA · recruiting

Other Consorcio Centro de Investigación Biomédica en Red (CIBER) trials

Trials by the same sponsor.

NCT07314177 — Effects of Three Dietary Strategies on Body Composition and Metabolic Health in Adults With Overweight or Obesity · NA · completed
NCT06060886 — Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis · Phase 4 · unknown
NCT04504968 — Effectiveness of a Multimodal Intervention on Function in Older Frail People With Diabetes in Latinamerican · NA · unknown
NCT04457505 — One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19 · completed
NCT06317883 — Childhood Obesity Risk Assessment Longitudinal Study · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06055504 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Consorcio Centro de Investigación Biomédica en Red (CIBER)
Last refreshed: 28 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06055504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing